title: Newer drugs for refractory and relapsed multiple myeloma are effective but costly, review finds.
authors.affiliation: Seattle.
authors.forename: Michael
authors.initials: M
authors.lastname: McCarthy
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000191:economics*; D006801:Humans; D009101:Multiple Myeloma / Q000188:drug therapy*; D009364:Neoplasm Recurrence, Local; D016896:Treatment Outcome; D014481:United States